3 terminated, 2 completed. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Terminated 1 |
Follow palifosfamide lysine: new trials by email Literature Review of palifosfamide lysine trials Research Report on palifosfamide lysine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors palifosfamide - Adult Central Nervous System Germ Cell Tumor, Adult Teratoma | Phase 2 | Terminated | Indiana University | 5 | 2013-02-01 | 2015-07-02 |
| Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma Palifosfamide-Tris, doxorubicin, Placebo - Soft Tissue Sarcoma | Phase 3 | Terminated | Alaunos Therapeutics | 447 | 2010-08-16 | 2026-10-06 |
| A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma Palifosfamide-Tris, Doxorubicin - Soft Tissue Sarcoma | Phase 2 | Terminated | Alaunos Therapeutics | 67 | 2008-09-03 | 2026-10-05 |
| Study of ZIO-201 in Advanced Sarcoma ZIO-201 - Advanced Sarcoma | Phase 1 / Phase 2 | Completed | Alaunos Therapeutics | 54 | 2006-02-21 | 2026-10-05 |
| A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer ZIO-201 - Advanced Cancer | Phase 1 | Completed | Alaunos Therapeutics | 30 | 2006-02-01 | 2009-09-17 |
Sarcoma (2) · Neoplasm Metastasis (1) · Teratoma (1) · Testicular Neoplasms (1)
Alaunos Therapeutics (4) · Indiana University (1)
United States (5) · Italy (2) · Romania (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · France (1) · Germany (1) · Guatemala (1) · India (1) · Israel (1)
Jonathan Lewis, MD, PhD (2) · Jonathan J Lewis, MD, PhD (1) · Lawrence H Einhorn, MD (1)